XILINX, INC. | |||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
(In thousands) | |||
|
| September 28, 2019 |
| March 30, 2019 * |
|
| (unaudited) |
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash, cash equivalents and short-term investments | $ 2,515,843 |
| $ 3,175,684 |
Accounts receivable, net | 335,499 |
| 335,165 |
Inventories | 335,258 |
| 315,358 |
Other current assets | 71,400 |
| 65,771 |
Total current assets | 3,258,000 |
| 3,891,978 |
Net property, plant and equipment | 362,160 |
| 328,929 |
Long-term investments | - |
| 53,433 |
Other assets | 1,399,738 |
| 877,008 |
Total Assets | $ 5,019,898 |
| $ 5,151,348 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable and accrued liabilities | $ 505,828 |
| $ 475,036 |
Long-term debt | 1,245,631 |
| 1,234,807 |
Other long-term liabilities | 572,534 |
| 579,996 |
Stockholders' equity | 2,695,905 |
| 2,861,509 |
Total Liabilities and Stockholders' Equity | $ 5,019,898 |
| $ 5,151,348 |
|
|
*Fiscal 2019 balances are derived from audited financial statements. |
XILINX, INC. | |||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | |||||||||
(Unaudited) | |||||||||
(In thousands) | |||||||||
|
| Three Months Ended |
| Six Months Ended | ||||||
|
| September 28, 2019 |
| June 29, 2019 |
| September 29, 2018 |
| September 28, 2019 |
| September 29, 2018 |
SELECTED CASH FLOW INFORMATION: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization of software | $ 22,438 |
| $ 20,113 |
| $ 16,048 |
| $ 42,551 |
| $ 31,123 |
| Amortization - others | 12,965 |
| 9,085 |
| 8,144 |
| 22,050 |
| 15,477 |
| Stock-based compensation | 49,822 |
| 42,753 |
| 34,945 |
| 92,575 |
| 70,553 |
| Net cash provided by operating activities | 223,694 |
| 298,216 |
| 313,123 |
| 521,910 |
| 489,291 |
| Purchases of property, plant and equipment and software | 33,641 |
| 29,201 |
| 14,174 |
| 62,842 |
| 40,533 |
| Payment of dividends to stockholders | 93,484 |
| 93,961 |
| 91,077 |
| 187,445 |
| 181,752 |
| Repurchases of common stock | 32,250 |
| 444,995 |
| 23,236 |
| 477,245 |
| 160,536 |
| Taxes paid related to net share settlement of restricted stock units, net of proceeds from issuance of common stock | 47,857 |
| 4,119 |
| 15,797 |
| 51,976 |
| 21,078 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STOCK-BASED COMPENSATION INCLUDED IN: |
|
|
|
|
|
|
|
|
|
| Cost of revenues | $ 2,812 |
| $ 2,613 |
| $ 2,249 |
| $ 5,425 |
| $ 4,284 |
| Research and development | 29,702 |
| 24,874 |
| 20,047 |
| 54,576 |
| 40,977 |
| Selling, general and administrative | 17,308 |
| 15,266 |
| 12,649 |
| 32,574 |
| 25,292 |
